Ghosh A, Sinha A, Ghosh A, Roy S, Mallick S, Kumar V
Hum Genomics. 2024; 18(1):91.
PMID: 39210444
PMC: 11360852.
DOI: 10.1186/s40246-024-00660-2.
Tian Y, Li X, Bai C, Yang Z, Zhang L, Luo J
Mediators Inflamm. 2023; 2023:4003618.
PMID: 37228901
PMC: 10205412.
DOI: 10.1155/2023/4003618.
Ullah I, Yang L, Yin F, Sun Y, Li X, Li J
Cancers (Basel). 2022; 14(22).
PMID: 36428637
PMC: 9688479.
DOI: 10.3390/cancers14225545.
Recalde M, Garate-Rascon M, Herranz J, Elizalde M, Azkona M, Unfried J
Cancers (Basel). 2022; 14(9).
PMID: 35565178
PMC: 9102946.
DOI: 10.3390/cancers14092048.
Supplitt S, Karpinski P, Sasiadek M, Laczmanska I
Int J Mol Sci. 2021; 22(3).
PMID: 33572595
PMC: 7866970.
DOI: 10.3390/ijms22031422.
PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression.
Sun J, Zhang Y, Li B, Dong Y, Sun C, Zhang F
Cell Death Dis. 2019; 10(11):844.
PMID: 31700026
PMC: 6838072.
DOI: 10.1038/s41419-019-2067-2.
DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.
Wu Q, Ma J, Meng W, Hui P
Cancer Biol Ther. 2019; 21(1):17-25.
PMID: 31591939
PMC: 7012178.
DOI: 10.1080/15384047.2019.1647050.
Knockdown of LINC00511 promotes radiosensitivity of thyroid carcinoma cells via suppressing JAK2/STAT3 signaling pathway.
Chen Y, Bao C, Zhang X, Lin X, Fu Y
Cancer Biol Ther. 2019; 20(9):1249-1257.
PMID: 31135274
PMC: 6741561.
DOI: 10.1080/15384047.2019.1617569.
LncRNA ANCR promotes proliferation and radiation resistance of nasopharyngeal carcinoma by inhibiting PTEN expression.
Ma X, Zhou J, Liu J, Wu G, Yu Y, Zhu H
Onco Targets Ther. 2018; 11:8399-8408.
PMID: 30568463
PMC: 6267624.
DOI: 10.2147/OTT.S182573.
In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.
Rizzo A, Donzelli S, Girgenti V, Sacconi A, Vasco C, Salmaggi A
J Exp Clin Cancer Res. 2017; 36(1):76.
PMID: 28587680
PMC: 5460451.
DOI: 10.1186/s13046-017-0546-9.
Exploring the molecular pathogenesis and biomarkers of high risk oral premalignant lesions on the basis of long noncoding RNA expression profiling by serial analysis of gene expression.
Jia H, Wang X, Sun Z
Eur J Cancer Prev. 2017; 27(4):370-378.
PMID: 28418939
PMC: 6012059.
DOI: 10.1097/CEJ.0000000000000346.
Identification of a six-lncRNA signature associated with recurrence of ovarian cancer.
Yang K, Hou Y, Li A, Li Z, Wang W, Xie H
Sci Rep. 2017; 7(1):752.
PMID: 28389671
PMC: 5429632.
DOI: 10.1038/s41598-017-00763-y.
Massive Effect on LncRNAs in Human Monocytes During Fungal and Bacterial Infections and in Response to Vitamins A and D.
Riege K, Holzer M, Klassert T, Barth E, Brauer J, Collatz M
Sci Rep. 2017; 7:40598.
PMID: 28094339
PMC: 5240112.
DOI: 10.1038/srep40598.
Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J, Zhuang C, Liu Y, Chen M, Chen Y, Chen Z
J Exp Clin Cancer Res. 2016; 35(1):99.
PMID: 27328915
PMC: 4915162.
DOI: 10.1186/s13046-016-0372-5.
MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2.
Jiang B, Mu W, Wang J, Lu J, Jiang S, Li L
J Exp Clin Cancer Res. 2016; 35:69.
PMID: 27095063
PMC: 4837633.
DOI: 10.1186/s13046-016-0348-5.
MicroRNAs in Myeloid Hematological Malignancies.
Ciccone M, Calin G
Curr Genomics. 2016; 16(5):336-48.
PMID: 27047254
PMC: 4763972.
DOI: 10.2174/138920291605150710122815.
RNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral Load.
Poltronieri P, Sun B, Mallardo M
Curr Genomics. 2016; 16(5):327-35.
PMID: 27047253
PMC: 4763971.
DOI: 10.2174/1389202916666150707160613.
Cancer: we should not forget the past.
Di Lonardo A, Nasi S, Pulciani S
J Cancer. 2015; 6(1):29-39.
PMID: 25553086
PMC: 4278912.
DOI: 10.7150/jca.10336.
ptRNApred: computational identification and classification of post-transcriptional RNA.
Gupta Y, Witte M, Moller S, Ludwig R, Restle T, Zillikens D
Nucleic Acids Res. 2014; 42(22):e167.
PMID: 25303994
PMC: 4267668.
DOI: 10.1093/nar/gku918.
Noncoding RNAs in endocrine malignancy.
Kentwell J, Gundara J, Sidhu S
Oncologist. 2014; 19(5):483-91.
PMID: 24718512
PMC: 4012972.
DOI: 10.1634/theoncologist.2013-0458.